ARCUTIS BIOTHERAPEUTICS INC
ARQTNASDAQ🏆 #1524 by market capEarnings Oct 27US Equity
$26.18▼ $0.05 (−0.21%)
Live1h▼ 0.1%
24h▼ 0.2%
7d▼ 3.0%
14d▼ 6.1%
30d▼ 3.5%
1y▲ 77.5%
🏦Market Cap
$3.27B
Small Cap
📈Revenue Growth (YoY)
+76.1%
High Growth
📊Gross Margin
91.1%
High
💵FCF Margin
—
⚖️P/S Ratio
7.0x
Fair
Otter Score
55
Weak
Earnings
Q3 · 2026Reported 2026-08-05Earnings Per Share
Actual
0.11
Expected
0.06
beat
+99.70%
YoY +184.60%
Revenue
Actual
$129.86M
Expected
$118.85M
beat
+9.30%
YoY +59.30%
Consensus estimates
Recent quarters
Q3 2026
0.11
beat
Q2 2026
-0.09
miss
Q1 2026
0.13
beat
Q4 2025
0.06
beat